On September 4, 2019 Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, reported that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the following investor conferences (Press release, Leap Therapeutics, SEP 4, 2019, View Source [SID1234539289]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The H.C. Wainwright 2019 Global Investment Conference in New York City on Monday, September 9, 2019 at 8:20 a.m. ET.
The Ladenburg Thalmann 2019 Healthcare Conference in New York City on Tuesday, September 24, 2019 at 2:00 p.m. ET.
The presentations will be webcast live and may be accessed on the Investors page of the company’s website at www.investors.leaptx.com, where a replay of the events will also be available for a limited time.